JP2021534221A5 - - Google Patents

Info

Publication number
JP2021534221A5
JP2021534221A5 JP2021510959A JP2021510959A JP2021534221A5 JP 2021534221 A5 JP2021534221 A5 JP 2021534221A5 JP 2021510959 A JP2021510959 A JP 2021510959A JP 2021510959 A JP2021510959 A JP 2021510959A JP 2021534221 A5 JP2021534221 A5 JP 2021534221A5
Authority
JP
Japan
Prior art keywords
substituted
unsubstituted
compound
group
composition
Prior art date
Application number
JP2021510959A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021534221A (ja
JPWO2020047186A5 (https=
JP7495138B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/048703 external-priority patent/WO2020047186A1/en
Publication of JP2021534221A publication Critical patent/JP2021534221A/ja
Publication of JP2021534221A5 publication Critical patent/JP2021534221A5/ja
Publication of JPWO2020047186A5 publication Critical patent/JPWO2020047186A5/ja
Priority to JP2024080082A priority Critical patent/JP7777263B2/ja
Application granted granted Critical
Publication of JP7495138B2 publication Critical patent/JP7495138B2/ja
Priority to JP2025153392A priority patent/JP2025183370A/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021510959A 2018-08-29 2019-08-29 ステロイド受容体コアクチベーター－３の小分子刺激因子ならびに心臓保護剤及び／または血管再生剤としてのそれらの使用方法 Active JP7495138B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2024080082A JP7777263B2 (ja) 2018-08-29 2024-05-16 ステロイド受容体コアクチベーター－３の小分子刺激因子ならびに心臓保護剤及び／または血管再生剤としてのそれらの使用方法
JP2025153392A JP2025183370A (ja) 2018-08-29 2025-09-16 ステロイド受容体コアクチベーター－３の小分子刺激因子ならびに心臓保護剤及び／または血管再生剤としてのそれらの使用方法

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201862724281P 2018-08-29 2018-08-29
US62/724,281 2018-08-29
US201962825358P 2019-03-28 2019-03-28
US62/825,358 2019-03-28
PCT/US2019/048703 WO2020047186A1 (en) 2018-08-29 2019-08-29 Small molecule stimulators of steroid receptor coactivator-3 and methods of their use as cardioprotective and/or vascular regenerative agents

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024080082A Division JP7777263B2 (ja) 2018-08-29 2024-05-16 ステロイド受容体コアクチベーター－３の小分子刺激因子ならびに心臓保護剤及び／または血管再生剤としてのそれらの使用方法

Publications (4)

Publication Number Publication Date
JP2021534221A JP2021534221A (ja) 2021-12-09
JP2021534221A5 true JP2021534221A5 (https=) 2022-09-02
JPWO2020047186A5 JPWO2020047186A5 (https=) 2022-09-02
JP7495138B2 JP7495138B2 (ja) 2024-06-04

Family

ID=67982135

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2021510959A Active JP7495138B2 (ja) 2018-08-29 2019-08-29 ステロイド受容体コアクチベーター－３の小分子刺激因子ならびに心臓保護剤及び／または血管再生剤としてのそれらの使用方法
JP2024080082A Active JP7777263B2 (ja) 2018-08-29 2024-05-16 ステロイド受容体コアクチベーター－３の小分子刺激因子ならびに心臓保護剤及び／または血管再生剤としてのそれらの使用方法
JP2025153392A Pending JP2025183370A (ja) 2018-08-29 2025-09-16 ステロイド受容体コアクチベーター－３の小分子刺激因子ならびに心臓保護剤及び／または血管再生剤としてのそれらの使用方法

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2024080082A Active JP7777263B2 (ja) 2018-08-29 2024-05-16 ステロイド受容体コアクチベーター－３の小分子刺激因子ならびに心臓保護剤及び／または血管再生剤としてのそれらの使用方法
JP2025153392A Pending JP2025183370A (ja) 2018-08-29 2025-09-16 ステロイド受容体コアクチベーター－３の小分子刺激因子ならびに心臓保護剤及び／または血管再生剤としてのそれらの使用方法

Country Status (7)

Country Link
US (4) US10875841B2 (https=)
EP (1) EP3843843A1 (https=)
JP (3) JP7495138B2 (https=)
CN (2) CN120136844A (https=)
AU (2) AU2019333119B2 (https=)
CA (1) CA3110839A1 (https=)
WO (1) WO2020047186A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN120136844A (zh) * 2018-08-29 2025-06-13 贝勒医学院 类固醇受体共激活剂-3的小分子刺激剂以及它们用作心脏保护剂和/或血管再生剂的方法
KR20230093329A (ko) 2020-10-28 2023-06-27 베이롤 칼리지 오브 메드신 암의 치료를 위한 면역조절 치료제로서 면역 세포에서 src-3의 표적화
WO2025240566A1 (en) * 2024-05-17 2025-11-20 Baylor College Of Medicine Small molecule steroid receptor coactivator stimulators for use in repairing tissue

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL112205A0 (en) 1994-01-06 1995-03-15 Res Dev Foundation Curcumin, analogues of curcumin and novel uses thereof
CA2393440A1 (en) 1999-12-03 2001-06-07 Emory University Curcumin analogs with anti-tumor and anti-angiogenic properties
CA2395191A1 (en) 1999-12-23 2001-06-28 Tedman Ehlers Chalcone and its analogs as agents for the inhibition of angiogenesis and related disease states
US20070010488A1 (en) 2005-04-13 2007-01-11 Khairia Youssef Compounds for modulating cell proliferation
CN102381951B (zh) 2007-01-22 2013-09-04 温州医学院生物与天然药物开发中心有限公司 含环己酮的姜黄素单羰基结构类似物及其用途
EP2170311A4 (en) 2007-05-16 2011-10-19 Avalon Pharmaceuticals COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING AUTOIMMUNE DISEASES
WO2008150899A1 (en) 2007-05-29 2008-12-11 Emory University Combination therapies for treatment of cancer and inflammatory diseases
US20100197584A1 (en) 2007-07-27 2010-08-05 Research Foundations of the City University of- New York Use of curcumin to block brain tumor formation in mice
WO2009144220A1 (en) 2008-05-29 2009-12-03 Universite Libre De Bruxelles Water soluble curcumin compositions for use in anti-cancer and anti-inflammatory therapy
US8420118B2 (en) * 2009-09-10 2013-04-16 The Board Of Regents Of The University Of Oklahoma Anionic lipids and lipid nano-structures and methods of producing and using same
WO2011029359A1 (zh) 2009-09-12 2011-03-17 温州医学院 含11β-羟基甾体脱氢酶1双重调节剂的药物及其应用
JP2011074024A (ja) * 2009-09-30 2011-04-14 Shiseido Co Ltd ヘパラナーゼ活性阻害剤並びにそれを含有するしわ改善剤及び医薬組成物
WO2011127333A2 (en) 2010-04-09 2011-10-13 University Of Louisville Research Foundation, Inc. Compounds for treating disease, for administering, and for pharmaceutical compositions
WO2012021692A1 (en) 2010-08-11 2012-02-16 Rutgers, The State University Of New Jersey Curcumin analogs and methods of use thereof
CN102153508B (zh) * 2010-10-08 2013-01-09 福建医科大学 3,5-(e)-二亚苄基-n-环丙基哌啶-4-酮及其在制备治疗抗肿瘤药物中的应用
CN103012088B (zh) 2012-11-28 2017-01-11 江苏药兴医药股份有限公司 α-(3,5-二甲氧基苯亚甲基)-α'-烃基亚甲基环酮及其制备方法
ITMI20130075A1 (it) 2013-01-21 2014-07-22 Altergon Sa Combinazione orale per la prevenzione e il trattamento di patologie vescicali, pelviche e dell¿apparato uro-genitale
CN103181922A (zh) * 2013-04-02 2013-07-03 温州医学院 一类含哌啶酮的单羰基姜黄素类化合物在制备抗炎药物中的应用
WO2016109470A1 (en) 2014-12-30 2016-07-07 Baylor College Of Medicine Small molecule stimulators of steroid receptor coactivator proteins and their use in the treatment of cancer
WO2017062751A1 (en) * 2015-10-08 2017-04-13 The Regents Of The University Of California Compounds and methods for promoting stress resistance
CN106083704B (zh) * 2016-06-06 2018-07-27 福建医科大学 3,5-(E)-二芳亚甲基-N-环丙基哌啶-4-酮类化合物作为Hsp90抑制剂的应用
EP3713916A1 (en) * 2017-11-20 2020-09-30 Kiakos, Konstantinos 3,5-diarylidenyl-n-substituted-piperid-4-one-derived inhibitors of stat3 pathway acitivty and uses therof
CN120136844A (zh) * 2018-08-29 2025-06-13 贝勒医学院 类固醇受体共激活剂-3的小分子刺激剂以及它们用作心脏保护剂和/或血管再生剂的方法

Similar Documents

Publication Publication Date Title
JP2021534221A5 (https=)
JP2011509309A5 (https=)
RU2008119692A (ru) Новые 1-азабициклоалкилпроизводные для лечения психических растройств
JP2021105002A5 (https=)
JP2017524025A5 (https=)
JP2016513663A5 (https=)
JP2012532883A5 (https=)
JP2010506854A5 (https=)
JP2013056919A5 (https=)
JP2014506907A5 (https=)
JP2019513745A5 (https=)
JP2016518437A5 (https=)
JP2020517707A5 (https=)
JP2011500758A5 (https=)
JP2019510794A5 (https=)
JPWO2023099592A5 (https=)
JP2020128426A5 (https=)
JP2015500223A5 (https=)
JP2014532730A5 (ja) オピオイド受容体の調節物質およびそれを含む薬学的組成物
MA45888A1 (fr) Inhibiteurs de tyrosine kinase de bruton
JP2019535723A5 (https=)
JP2013542267A5 (https=)
JP2019527724A5 (https=)
JP2012518649A5 (https=)
JP2004525183A5 (https=)